Kalaris Therapeutics (KLRS) EBIT (2019 - 2026)
Kalaris Therapeutics (KLRS) posted EBIT of -$12.39 million for Q2 2026, compared with -$12.26 million a year earlier.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) EBIT (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Kalaris Therapeutics was -$47.76 million; for FY2025, it came in at -$46.15 million.
- In prior years, Kalaris Therapeutics' EBIT was -$51.73 million in FY2024, -$199.9 million in FY2023, -$171.2 million in FY2022 and -$169.82 million in FY2021.
- Quarterly EBIT has run from a low of -$62.41 million in Q4 2023 to a high of -$2.56 million in Q1 2024 over five years.
- According to Business Quant data, EBIT for the three prior quarters was -$11.83 million (Q1 2026), -$10.8 million (Q4 2025) and -$12.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Kalaris Therapeutics | 44.52 Mn | -38.38 Mn | - | -11.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -11.81 Mn |
| Jun 30, 2026 | -12.39 Mn |
| Mar 31, 2026 | -11.83 Mn |
| Dec 31, 2025 | -10.80 Mn |
| Sep 30, 2025 | -12.74 Mn |
| Jun 30, 2025 | -12.26 Mn |
| Mar 31, 2025 | -10.35 Mn |
| Dec 31, 2024 | -7.13 Mn |
| Sep 30, 2024 | -37.85 Mn |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | -2.56 Mn |
| Dec 31, 2023 | -62.41 Mn |
| Sep 30, 2023 | -46.96 Mn |
| Jun 30, 2023 | -47.30 Mn |
| Mar 31, 2023 | -43.23 Mn |
| Dec 31, 2022 | -40.43 Mn |
| Sep 30, 2022 | -42.95 Mn |
| Jun 30, 2022 | -44.62 Mn |
| Mar 31, 2022 | -43.19 Mn |
| Dec 31, 2021 | -55.80 Mn |
API Access
Kalaris Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();